2020 American Transplant Congress Archives - Page 52 of 223

ATC Virtual Congress
Live Broadcast Dates: May 30 - June 1, 2020
OnDemand Access: May 30, 2020 - June 4, 2021

Originally scheduled to take place in Philadelphia, this became a Virtual Congress due to COVID-19. For more information, visit The Official ATC Congress site.

Saturday, May 30, 2020

3:30pm-4:00pm: Cytomegalovirus Preemptive Monitoring Conversion and the Use of a Preemptive Threshold after Solid Organ Transplant

C. Wong, M. Jorgenson, J. Descourouez, C. Saddler, J. Smith, D. Mandelbrot

Poster Session B: Kidney Infectious Excluding Polyoma & Viral Hepatitis • Virtual

3:30pm-4:00pm: Daily Immunosuppression to Combat Compliance in Adolescent Kidney Transplant

A. L. Brubaker¹, A. McGrath², L. Maestretti², A. Chaudhuri², P. C. Grimm², A. Gallo¹

Poster Session A: Kidney: Pediatrics • Virtual

3:30pm-4:00pm: DAMPs and NLRP3 Inflammasome Response in Fatty Liver Grafts Preservation in Different Preservation Solutions

R. G. Bardallo¹, R. G. Teixeira-Silva², A. Panisello-Rosello³, E. Folch-Puy³, J. Rosello Catafau⁴, T. Carbonell⁵

Poster Session D: Ischemia Reperfusion & Organ Rehabilitation • Virtual

3:30pm-4:00pm: Daratumumab for Desensitization and Antibody Mediated Rejection Treatment in Highly-HLA Sensitized Patients

S. Jordan, R. Vescio, N. Ammerman, M. Toyoda, S. Ge, M. Chu, J. Hou, E. Huang, A. Peng, S. Sethi, R. Najjar, K. Lim, J. Kobashigawa, J. Patel, E. Kransdorf, A. Vo

Poster Session A: Kidney Acute Antibody Mediated Rejection • Virtual

3:30pm-4:00pm: DCD vs DBD Liver Transplantation: Equivalent Charges and Similar Survival- An Effective Expansion of the Donor Pool

N. Singh, K. Helfrich, M. Alebrahim, C. Akateh, K. Mumtaz, A. Logan, A. Schenk, S. Black, E. Elkhammas, K. Washburn, A. El-Hinnawi

Poster Session D: Liver: MELD, Allocation and Donor Issues (DCD/ECD) • Virtual

3:30pm-4:00pm: dd-cfDNA as a Risk Factor for Initiating De-Novo Donor Specific Antibodies in Heart Transplantation

E. DePasquale¹, J. Kobashigawa², S. Pinney³, K. Khush⁴

Poster Session A: Biomarkers, Immune Assessment and Clinical Outcomes • Virtual

3:30pm-4:00pm: De Novo Dosing and Trough Attainment Trends of Extended-Release Tacrolimus in the Absence of Dose Adjustments

M. J. Moritz¹, D. R. Stevens², U. Meier-Kriesche², T. A. Horwedel²

Poster Session D: Kidney Immunosuppression: Novel Regimens and Drug Minimization • Virtual

3:30pm-4:00pm: De Novo Dosing of LCP-Tacrolimus Using Conservative Weight-Based Strategy Resulted in Supratherapeutic Trough Levels in Majority of Patients

J. Dann, J. Geyston, M. Wassimi, K. Brayman, A. Doyle

Poster Session D: Kidney Immunosuppression: Novel Regimens and Drug Minimization • Virtual

3:30pm-4:00pm: De Novo DSA in the Setting of Stable Renal Allograft Function Does Not Impair Long-Term Graft Survival

R. Knight¹, D. T. Nguyen², E. A. Graviss², O. Gaber¹

Poster Session D: Kidney Complications: Immune Mediated Late Graft Failure • Virtual

3:30pm-4:00pm: De Novo Malignancy after Liver Transplantation for Alcoholic Cirrhosis: Incidence and Outcomes

M. M. Pascale, E. Nure, G. Bianco, F. Frongillo, S. Agnes

Poster Session C: PTLD/Malignancies: All Topics • Virtual